Dr. Andrzej M. Jasek, MD

Dr. Jasek practices at Orthomidwest in Rockford, Illinois.

Dr. Jasek's NPI, 1578636692, was assigned on November 16, 2006. Dr. Jasek graduated from Medical University of Warsaw in 1985. Dr. Jasek holds Illinois license 036-092808.

Dr. Jasek's primary practice is Orthomidwest, at 5875 E Riverside Blvd, Rockford, IL 61114 in Winnebago County. The practice phone is (815) 398-9491.

Dr. Jasek's primary practice is Orthomidwest in Rockford, Illinois. Dr. Jasek is also affiliated with UW Health SwedishAmerican Hospital. The medical group on file is OrthoIllinois. Dmand AI also links Dr. Jasek to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jasek practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Jasek's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Jasek is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Jasek's licenses on file in 3 states: Illinois, Wisconsin and Pennsylvania.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, lupus, muscle pain, fibromyalgia, and limb pain, osteoporosis and rheumatoid arthritis among the conditions Dr. Jasek treats.

CMS data shows 171,412 Medicare services from Dr. Jasek across 35 procedure codes in 2024, for 724 Medicare patients. Medicare paid $1,840,298 for them. Every service was in an office.

CMS counts 724 Medicare patients who saw Dr. Jasek in 2024. The largest group is 65 to 74, with 327 patients. 75% of them have arthritis, and 72% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jasek's median patient age at 71, with 78% women.

In 2024, Dr. Jasek wrote 5,157 Medicare Part D claims for 758 patients. 89% of them were for generic drugs. CMS names the drug for 4,875 of them, across 48 drugs with 11 or more claims each, at $2,398,218 in total drug cost. In 2023, CMS named 4,722 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Jasek for performance year 2024, reported as part of a group. Dr. Jasek accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Jasek to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Arthritis, Rheumatoid and Rheumatic Diseases. Open Payments lists research payments to Dr. Jasek that name 2 trials.

CMS Open Payments shows 438 general payments to Dr. Jasek from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $2,092. It also lists 5 research payments totaling $5,550 from 2016 to 2023, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Jasek, most recently CMS Stage 1 EHR in 2012.

Dr. Jasek graduated from Medical University of Warsaw in 1985.

Dr. Jasek is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.